SE0103754D0 - Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density lipoprotein - Google Patents
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density lipoproteinInfo
- Publication number
- SE0103754D0 SE0103754D0 SE0103754A SE0103754A SE0103754D0 SE 0103754 D0 SE0103754 D0 SE 0103754D0 SE 0103754 A SE0103754 A SE 0103754A SE 0103754 A SE0103754 A SE 0103754A SE 0103754 D0 SE0103754 D0 SE 0103754D0
- Authority
- SE
- Sweden
- Prior art keywords
- peptide
- atherosclerosis
- determination
- development
- treatment
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 2
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (101)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103754A SE0103754L (sv) | 2001-04-05 | 2001-11-09 | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
US10/115,072 US20030105003A1 (en) | 2001-04-05 | 2002-04-04 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
PL391615A PL217858B1 (pl) | 2001-04-05 | 2002-04-05 | Fragment apolipoproteiny B lub jego miejsce aktywne, zawierająca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu, szczepionka zawierająca przeciwciało przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciała |
CN201210322795.9A CN103122031B (zh) | 2001-04-05 | 2002-04-05 | 以肽为基础的治疗动脉粥样硬化的免疫疗法 |
BRPI0216049A BRPI0216049B8 (pt) | 2001-04-05 | 2002-04-05 | "terapia de imunização à base de peptídeo para tratamento de arteriosclerose" |
JP2002578993A JP2004529143A (ja) | 2001-04-05 | 2002-04-05 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
EP10181227A EP2289932A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EEP200300487A EE200300487A (et) | 2001-04-05 | 2002-04-05 | Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu |
DE60230029T DE60230029D1 (de) | 2001-04-05 | 2002-04-05 | Immunisierungstherapie zur behandlung von atherosklerose |
EP10180188A EP2289916A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181263A EP2295463A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180111A EP2289914A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180026A EP2295457A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP08167532A EP2147680A3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181196A EP2289928A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EEP200700052A EE200700052A (et) | 2001-04-05 | 2002-04-05 | Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu |
ES10181267.5T ES2546293T3 (es) | 2001-04-05 | 2002-04-05 | Terapia de inmunización basada en péptidos para el tratamiento de aterosclerosis que fija ApoB como objetivo |
EP10181173A EP2289926A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
BR0208685-9A BR0208685A (pt) | 2001-04-05 | 2002-04-05 | Terapia de imunização à base de peptìdio para tratamento de arteriosclerose e desenvolvimento de ensaio à base de peptìdio para determinação de respostas imunes contra lipoproteìna oxidada de baixa densidade |
AU2002246484A AU2002246484B8 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180115A EP2305707A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181273A EP2289935A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180176A EP2305708A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
BRPI0216033A BRPI0216033B8 (pt) | 2001-04-05 | 2002-04-05 | "terapia de imunização à base de peptídio para tratamento de arteriosclerose" |
PL400308A PL400308A1 (pl) | 2001-04-05 | 2002-04-05 | Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci |
EP10180828A EP2289921A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180823A EP2289919A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
DK02714667T DK1383526T3 (da) | 2001-04-05 | 2002-04-05 | Immuniseringsterapi til behandling af aterosklerose |
EP10180172A EP2289915A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
AT02714667T ATE415423T1 (de) | 2001-04-05 | 2002-04-05 | Immunisierungstherapie zur behandlung von atherosklerose |
EP10180099A EP2295458A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180091A EP2305706A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180184A EP2295462A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP08167533A EP2147930A3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP08151489A EP2006301B1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis |
EP10181245A EP2289933A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180199A EP2289918A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP08167531A EP2147929A3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181267.5A EP2295464B1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis targeting ApoB100 |
EP10181203A EP2289929A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
PL02367301A PL367301A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180193A EP2289917A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180838A EP2289923A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180162.9A EP2295460B1 (en) | 2001-04-05 | 2002-04-05 | Peptide- or antibody-based immunization therapy for treatment of atherosclerosis targeting ApoB100 |
EP10180835A EP2289922A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP08158141A EP2147928A3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181167A EP2289925A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181213A EP2289930A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
DK10181267.5T DK2295464T3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for the treatment of atherosclerosis targeting ApoB100 |
CA2606839A CA2606839C (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
CA2443223A CA2443223C (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180156A EP2295459A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
IL15828502A IL158285A0 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein |
AT08151489T ATE510851T1 (de) | 2001-04-05 | 2002-04-05 | Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose |
PT02714667T PT1383526E (pt) | 2001-04-05 | 2002-04-05 | Terapia de imunização para o tratamento de aterosclerose |
CNA2009100095655A CN101486766A (zh) | 2001-04-05 | 2002-04-05 | 以肽为基础的治疗动脉粥样硬化的免疫疗法,和以肽为基础的用于确定针对氧化低密度脂蛋白的免疫反应的检测方法 |
EP10180106A EP2289912A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
DK08151489.5T DK2006301T3 (da) | 2001-04-05 | 2002-04-05 | Peptid-baseret immuniseringsterapi til behandling af atherosklerose |
PL385189A PL215401B1 (pl) | 2001-04-05 | 2002-04-05 | Fragment apolipoproteiny B lub jego miejsce aktywne, zawierajaca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu , szczepionka zawierajaca przeciwcialo przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciala |
CN2007101953989A CN101284874B (zh) | 2001-04-05 | 2002-04-05 | 以肽为基础的治疗动脉粥样硬化的免疫疗法 |
EP10180845A EP2289924A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180826A EP2289920A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
RU2003132443/15A RU2296582C2 (ru) | 2001-04-05 | 2002-04-05 | Фрагменты пептидов, фармацевтические композиции и вакцины на их основе и их применение для профилактики и терапии атеросклероза |
CN028089405A CN1505525B (zh) | 2001-04-05 | 2002-04-05 | 以肽为基础的治疗动脉粥样硬化的免疫疗法,和以肽为基础的用于确定针对氧化低密度脂蛋白的免疫反应的检测方法 |
PCT/SE2002/000679 WO2002080954A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181253.5A EP2289934B1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis |
EP07119130A EP1918300A3 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis |
CA2827167A CA2827167A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180168A EP2295461A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10181188A EP2289927A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
ES02714667T ES2317999T3 (es) | 2001-04-05 | 2002-04-05 | Terapia de inmunizacion para el tratamiento de la ateroesclerosis. |
EP10181217A EP2289931A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP10180109A EP2289913A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
EP02714667A EP1383526B1 (en) | 2001-04-05 | 2002-04-05 | Immunization therapy for treatment of atherosclerosis |
IL158285A IL158285A (en) | 2001-04-05 | 2003-10-07 | Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein |
US11/485,549 US7537758B2 (en) | 2001-04-05 | 2006-07-12 | Antibodies against a peptide epitope of apolipoprotein B |
US11/924,010 US7527795B2 (en) | 2001-04-05 | 2007-10-25 | Peptide epitopes of apolipoprotein B |
US11/930,859 US7544360B2 (en) | 2001-04-05 | 2007-10-31 | Peptide epitopes of apolipoprotein B |
US11/930,910 US7556811B2 (en) | 2001-04-05 | 2007-10-31 | Peptide epitopes of apolipoprotein B |
US11/930,625 US7528225B2 (en) | 2001-04-05 | 2007-10-31 | Peptide epitopes of apolipoprotein B |
US11/930,969 US20090117137A1 (en) | 2001-04-05 | 2007-10-31 | Peptide epitopes of apolipoprotein b |
IL188286A IL188286A0 (en) | 2001-04-05 | 2007-12-20 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
JP2008015545A JP2008169215A (ja) | 2001-04-05 | 2008-01-25 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
IL195356A IL195356A0 (en) | 2001-04-05 | 2008-11-18 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
CY20091100202T CY1108817T1 (el) | 2001-04-05 | 2009-02-24 | Ανοσολογικη θεραπεια για την αντιμετωπιση της αθηροσκληρωσης |
US12/394,744 US20090226475A1 (en) | 2001-04-05 | 2009-02-27 | Peptide-based immunization therapy for treatment of atherosclerosis |
US12/394,857 US7704499B2 (en) | 2001-04-05 | 2009-02-27 | Antibodies against a peptide epitope of apoliporotein B |
US12/394,919 US8034336B2 (en) | 2001-04-05 | 2009-02-27 | Antibodies against a peptide epitope of apoliprotein B |
US12/394,886 US8029786B2 (en) | 2001-04-05 | 2009-02-27 | Antibodies against a peptide epitope of apolipoprotein B |
US12/394,787 US7785589B2 (en) | 2001-04-05 | 2009-02-27 | Antibodies against a peptide epitope of apolipoprotein B |
US12/394,827 US8025876B2 (en) | 2001-04-05 | 2009-02-27 | Antibodies against a peptide epitope of apolipoprotein B |
JP2009133383A JP5270456B2 (ja) | 2001-04-05 | 2009-06-02 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
US12/644,810 US20100183706A1 (en) | 2001-04-05 | 2009-12-22 | Peptide epitopes of apolipoprotein b |
JP2010239477A JP5300819B2 (ja) | 2001-04-05 | 2010-10-26 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
JP2010239478A JP5300820B2 (ja) | 2001-04-05 | 2010-10-26 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
US13/177,897 USRE43581E1 (en) | 2001-04-05 | 2011-07-07 | Peptide epitopes of apolipoprotein B |
US13/736,633 US8647628B2 (en) | 2001-04-05 | 2013-01-08 | Peptide epitopes of apolipoprotein B |
US13/736,644 US8642726B2 (en) | 2001-04-05 | 2013-01-08 | Peptide epitopes of apolipoprotein B |
US13/736,636 US8642043B2 (en) | 2001-04-05 | 2013-01-08 | Peptide epitopes of apolipoprotein B |
US13/736,645 US8470768B2 (en) | 2001-04-05 | 2013-01-08 | Peptide epitopes of apolipoprotein B |
JP2013034312A JP5613890B2 (ja) | 2001-04-05 | 2013-02-25 | アテローム性動脈硬化症の治療のためのペプチドに基づいた免疫治療、及び酸化した低密度リポ蛋白質に対する免疫応答の測定のためのペプチドベースのアッセーの開発 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101232A SE0101232D0 (sv) | 2001-04-05 | 2001-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein |
SE0103754A SE0103754L (sv) | 2001-04-05 | 2001-11-09 | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0103754D0 true SE0103754D0 (sv) | 2001-11-09 |
SE0103754L SE0103754L (sv) | 2002-10-06 |
Family
ID=26655437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103754A SE0103754L (sv) | 2001-04-05 | 2001-11-09 | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
Country Status (18)
Country | Link |
---|---|
EP (42) | EP2147930A3 (sv) |
JP (6) | JP2004529143A (sv) |
CN (4) | CN1505525B (sv) |
AT (2) | ATE415423T1 (sv) |
AU (1) | AU2002246484B8 (sv) |
BR (1) | BR0208685A (sv) |
CA (3) | CA2827167A1 (sv) |
CY (1) | CY1108817T1 (sv) |
DE (1) | DE60230029D1 (sv) |
DK (3) | DK1383526T3 (sv) |
EE (2) | EE200700052A (sv) |
ES (2) | ES2317999T3 (sv) |
IL (4) | IL158285A0 (sv) |
PL (4) | PL367301A1 (sv) |
PT (1) | PT1383526E (sv) |
RU (1) | RU2296582C2 (sv) |
SE (1) | SE0103754L (sv) |
WO (1) | WO2002080954A1 (sv) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
US20030105003A1 (en) | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
AU2002362612B2 (en) | 2001-09-28 | 2007-11-15 | Cedars-Sinai Medical Center | Prevention and treatment of restenosis by local administration of drug |
SE0302312D0 (sv) | 2002-10-04 | 2003-08-27 | Forskarpatent I Syd Ab | Peptide-based passive immunization therapy for treatment of atherosclerosis |
WO2004030607A2 (en) * | 2002-10-04 | 2004-04-15 | Forskarpatent I Syd Ab | Peptide-based passive immunization therapy for treatment of atherosclerosis |
SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
SE0400683D0 (sv) * | 2004-03-19 | 2004-03-19 | Forskarpatent I Syd Ab | Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis |
US8926958B2 (en) | 2004-04-06 | 2015-01-06 | Cedars-Sinai Medical Center | Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano |
PL1735349T3 (pl) | 2004-04-15 | 2011-03-31 | Athera Biotechnologies Ab | Sposób oceny ryzyka niedokrwiennego schorzenia układu sercowo-naczyniowego za pomocą koniugatów fosforylocholiny |
EP1676602A1 (en) | 2005-01-04 | 2006-07-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
GB0517878D0 (en) | 2005-09-02 | 2005-10-12 | Bioinvent Int Ab | Immunotherapeutic treatment |
WO2008080030A2 (en) * | 2006-12-22 | 2008-07-03 | Abbott Laboratories | Cardiovascular autoimmune disease panel and methods of using same |
WO2008104194A1 (en) * | 2007-02-28 | 2008-09-04 | Bioinvent International Ab | Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
AR065718A1 (es) | 2007-03-15 | 2009-06-24 | Novartis Ag | Compuestos heterociclicos nitrogenados,utiles en el diagnostico y tratamiento de trastornos hiperproliferativos. |
EP2538218A3 (en) * | 2007-11-05 | 2013-04-24 | Nordic Bioscience A/S | Biochemical markers for CVD risk assessment |
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
JP5742002B2 (ja) * | 2008-08-15 | 2015-07-01 | 藤倉化成株式会社 | 動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出を補助する方法、並びに動脈硬化診断用キット |
US9125850B2 (en) | 2009-11-14 | 2015-09-08 | Cardio Vax, Llc | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis |
US8506964B2 (en) * | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
US20130142760A1 (en) | 2010-08-18 | 2013-06-06 | Cedars-Sinai Medical Center | Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
US9205139B2 (en) | 2010-11-12 | 2015-12-08 | Cardiovax, Llc | Immunomodulatory methods and systems for treatment and/or prevention of aneurysms |
CA2817543A1 (en) * | 2010-11-12 | 2012-06-07 | Cedars-Sinai Medical Center | Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
EP2637686A2 (en) * | 2010-11-12 | 2013-09-18 | Cedars-Sinai Medical Center | Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100 |
TR201909072T4 (tr) | 2011-08-09 | 2019-08-21 | Athera Biotechnologies Ab | Fosforilkoline karşı yeni antikorlar. |
JP6277126B2 (ja) | 2011-08-09 | 2018-02-07 | アセラ・バイオテクノロジーズ・アーベー | ホスホリルコリン(pc)および/またはpcコンジュゲートに結合する抗体 |
RU2495048C1 (ru) * | 2012-04-18 | 2013-10-10 | Андрей Валентинович Исаев | Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов |
WO2014072916A1 (en) | 2012-11-06 | 2014-05-15 | Les Hopitaux Universitaires De Geneve | Mimetic peptides |
CN103520713B (zh) * | 2013-10-16 | 2015-10-28 | 西北农林科技大学 | 一种ApoB100酵母重组疫苗及其制备方法和应用 |
CN103860470A (zh) * | 2014-03-05 | 2014-06-18 | 贵州中泰生物科技有限公司 | 一种口服高密度脂蛋白脂质体的制备方法 |
CN105315364B (zh) * | 2014-06-17 | 2018-09-18 | 广州文瑞生物科技有限公司 | 胶原蛋白vi疫苗预防动脉粥样硬化 |
CN108135973B (zh) * | 2015-05-19 | 2021-10-19 | 拉·约拉过敏反应及免疫医学研究所 | 调节炎症应答及治疗不良心血管事件、病和粥样硬化的人apob100表位、方法和用途 |
US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
CN108478817B (zh) * | 2018-03-16 | 2020-10-27 | 北京大学 | 一种动脉粥样硬化检测试剂及其制备方法 |
CA3129373A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970144A (en) | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
US5972890A (en) | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
WO1993018067A1 (en) * | 1992-03-06 | 1993-09-16 | Abbott Laboratories | Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels |
WO1994000592A1 (en) * | 1992-06-26 | 1994-01-06 | Exocell, Inc. | Monoclonal antibodies against glycated low density lipoprotein |
CA2142007C (en) * | 1992-08-11 | 2007-10-30 | Robert Glen Urban | Immunomodulatory peptides |
KR0185334B1 (ko) | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
GB9609702D0 (en) * | 1996-05-09 | 1996-07-10 | Royal Free Hosp School Med | Anticoagulant peptides |
GB9620153D0 (en) * | 1996-09-27 | 1996-11-13 | Univ Strathclyde | Non-naturally occurring lipoprotein particle |
GB9705831D0 (en) * | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
US6635623B1 (en) * | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
US6225070B1 (en) | 1997-08-07 | 2001-05-01 | The Regents Of The University Of California | Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
US6156315A (en) * | 1997-10-10 | 2000-12-05 | The Trustees Of Columbia University In The City Of New York | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
US6309844B1 (en) * | 1997-10-15 | 2001-10-30 | Fujirebio Inc. | Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same |
EP1062512A4 (en) * | 1998-03-10 | 2001-12-12 | Univ California | METHODS AND TOOLS USED TO IDENTIFY COMPOUNDS THAT MODULATE ATHEROSCLEROSIS BY ALTERATION OF THE LDL-PROTEOGLYCANE BINDING |
WO2000002920A1 (en) * | 1998-07-13 | 2000-01-20 | University Of Otago | Inhibition of lipoprotein formation |
IL126447A (en) * | 1998-10-04 | 2004-09-27 | Vascular Biogenics Ltd | An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis |
EP1224461B1 (en) * | 1999-10-26 | 2011-04-20 | The Regents of The University of California | Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
AU3087801A (en) * | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
EP1267908B1 (en) * | 2000-03-03 | 2004-05-06 | GlaxoSmithKline Biologicals S.A. | Vaccine for the treatment of atherosclerosis |
SE0000855D0 (sv) * | 2000-03-15 | 2000-03-15 | Karolinska Innovations Ab | Antigenic composition useful as a vaccine against atherosclerosis |
GB0017641D0 (en) * | 2000-07-18 | 2000-09-06 | Medigene Oy | Peptides and their use |
EP1186299A1 (en) * | 2000-09-12 | 2002-03-13 | Universitair Medisch Centrum Utrecht | The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
AU2002243382A1 (en) * | 2000-10-25 | 2002-06-24 | Vincent Agnello | Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
WO2002042426A2 (en) * | 2000-11-10 | 2002-05-30 | University Of Utah Research Foundation | Carrier system for specific artery wall gene delivery |
SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
JP3944083B2 (ja) * | 2001-05-15 | 2007-07-11 | 株式会社Jimro | 高密度リポ蛋白質反応性ペプチド |
WO2003007689A2 (en) * | 2001-07-20 | 2003-01-30 | Eidgenoessische Technische Hochschule Zurich (Ethz) | Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
-
2001
- 2001-11-09 SE SE0103754A patent/SE0103754L/sv not_active Application Discontinuation
-
2002
- 2002-04-05 EP EP08167533A patent/EP2147930A3/en not_active Withdrawn
- 2002-04-05 EP EP10181173A patent/EP2289926A1/en not_active Withdrawn
- 2002-04-05 EP EP07119130A patent/EP1918300A3/en not_active Withdrawn
- 2002-04-05 AU AU2002246484A patent/AU2002246484B8/en not_active Expired
- 2002-04-05 EP EP10180111A patent/EP2289914A1/en not_active Withdrawn
- 2002-04-05 PL PL02367301A patent/PL367301A1/xx unknown
- 2002-04-05 AT AT02714667T patent/ATE415423T1/de active
- 2002-04-05 EP EP10181273A patent/EP2289935A1/en not_active Withdrawn
- 2002-04-05 EP EP08167532A patent/EP2147680A3/en not_active Withdrawn
- 2002-04-05 EP EP10181267.5A patent/EP2295464B1/en not_active Expired - Lifetime
- 2002-04-05 CN CN028089405A patent/CN1505525B/zh not_active Expired - Fee Related
- 2002-04-05 EP EP10181217A patent/EP2289931A1/en not_active Withdrawn
- 2002-04-05 RU RU2003132443/15A patent/RU2296582C2/ru active
- 2002-04-05 DK DK02714667T patent/DK1383526T3/da active
- 2002-04-05 EE EEP200700052A patent/EE200700052A/xx unknown
- 2002-04-05 DK DK10181267.5T patent/DK2295464T3/en active
- 2002-04-05 EP EP10180156A patent/EP2295459A1/en not_active Withdrawn
- 2002-04-05 EP EP10180091A patent/EP2305706A1/en not_active Withdrawn
- 2002-04-05 CA CA2827167A patent/CA2827167A1/en not_active Abandoned
- 2002-04-05 EP EP10180026A patent/EP2295457A1/en not_active Withdrawn
- 2002-04-05 EP EP10181263A patent/EP2295463A1/en not_active Withdrawn
- 2002-04-05 EP EP10181245A patent/EP2289933A1/en not_active Withdrawn
- 2002-04-05 PL PL385189A patent/PL215401B1/pl unknown
- 2002-04-05 EP EP10181203A patent/EP2289929A1/en not_active Withdrawn
- 2002-04-05 AT AT08151489T patent/ATE510851T1/de not_active IP Right Cessation
- 2002-04-05 EP EP10180826A patent/EP2289920A1/en not_active Withdrawn
- 2002-04-05 EP EP02714667A patent/EP1383526B1/en not_active Expired - Lifetime
- 2002-04-05 CN CN2007101953989A patent/CN101284874B/zh not_active Expired - Lifetime
- 2002-04-05 PT PT02714667T patent/PT1383526E/pt unknown
- 2002-04-05 CN CNA2009100095655A patent/CN101486766A/zh active Pending
- 2002-04-05 DK DK08151489.5T patent/DK2006301T3/da active
- 2002-04-05 EP EP10180835A patent/EP2289922A1/en not_active Withdrawn
- 2002-04-05 CN CN201210322795.9A patent/CN103122031B/zh not_active Expired - Lifetime
- 2002-04-05 CA CA2606839A patent/CA2606839C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180188A patent/EP2289916A1/en not_active Withdrawn
- 2002-04-05 EP EP10180172A patent/EP2289915A1/en not_active Withdrawn
- 2002-04-05 EP EP10180838A patent/EP2289923A1/en not_active Withdrawn
- 2002-04-05 DE DE60230029T patent/DE60230029D1/de not_active Expired - Lifetime
- 2002-04-05 EP EP10181227A patent/EP2289932A1/en not_active Withdrawn
- 2002-04-05 ES ES02714667T patent/ES2317999T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP10180184A patent/EP2295462A1/en not_active Withdrawn
- 2002-04-05 EP EP10180823A patent/EP2289919A1/en not_active Withdrawn
- 2002-04-05 CA CA2443223A patent/CA2443223C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181213A patent/EP2289930A1/en not_active Withdrawn
- 2002-04-05 EP EP08158141A patent/EP2147928A3/en not_active Withdrawn
- 2002-04-05 EP EP08151489A patent/EP2006301B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180199A patent/EP2289918A1/en not_active Withdrawn
- 2002-04-05 EP EP10180845A patent/EP2289924A1/en not_active Withdrawn
- 2002-04-05 EP EP08167531A patent/EP2147929A3/en not_active Ceased
- 2002-04-05 EP EP10180168A patent/EP2295461A1/en not_active Withdrawn
- 2002-04-05 WO PCT/SE2002/000679 patent/WO2002080954A1/en active Application Filing
- 2002-04-05 EP EP10180106A patent/EP2289912A1/en not_active Withdrawn
- 2002-04-05 EP EP10180109A patent/EP2289913A1/en not_active Withdrawn
- 2002-04-05 EP EP10180115A patent/EP2305707A1/en not_active Withdrawn
- 2002-04-05 EP EP10181196A patent/EP2289928A1/en not_active Withdrawn
- 2002-04-05 EP EP10181253.5A patent/EP2289934B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180162.9A patent/EP2295460B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180176A patent/EP2305708A1/en not_active Withdrawn
- 2002-04-05 PL PL391615A patent/PL217858B1/pl unknown
- 2002-04-05 EP EP10180828A patent/EP2289921A1/en not_active Withdrawn
- 2002-04-05 EP EP10181188A patent/EP2289927A1/en not_active Withdrawn
- 2002-04-05 ES ES10181267.5T patent/ES2546293T3/es not_active Expired - Lifetime
- 2002-04-05 BR BR0208685-9A patent/BR0208685A/pt not_active Application Discontinuation
- 2002-04-05 EP EP10180193A patent/EP2289917A1/en not_active Withdrawn
- 2002-04-05 IL IL15828502A patent/IL158285A0/xx unknown
- 2002-04-05 EE EEP200300487A patent/EE200300487A/xx unknown
- 2002-04-05 PL PL400308A patent/PL400308A1/pl unknown
- 2002-04-05 JP JP2002578993A patent/JP2004529143A/ja not_active Withdrawn
- 2002-04-05 EP EP10180099A patent/EP2295458A1/en not_active Withdrawn
- 2002-04-05 EP EP10181167A patent/EP2289925A1/en not_active Withdrawn
-
2003
- 2003-10-07 IL IL158285A patent/IL158285A/en active IP Right Grant
-
2007
- 2007-12-20 IL IL188286A patent/IL188286A0/en unknown
-
2008
- 2008-01-25 JP JP2008015545A patent/JP2008169215A/ja not_active Withdrawn
- 2008-11-18 IL IL195356A patent/IL195356A0/en unknown
-
2009
- 2009-02-24 CY CY20091100202T patent/CY1108817T1/el unknown
- 2009-06-02 JP JP2009133383A patent/JP5270456B2/ja not_active Expired - Fee Related
-
2010
- 2010-10-26 JP JP2010239477A patent/JP5300819B2/ja not_active Expired - Lifetime
- 2010-10-26 JP JP2010239478A patent/JP5300820B2/ja not_active Expired - Lifetime
-
2013
- 2013-02-25 JP JP2013034312A patent/JP5613890B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0103754D0 (sv) | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density lipoprotein | |
AT500379B8 (de) | Tau-proteine | |
ID26645A (id) | Protein-protein utant yang memiliki respons alergenik yang lebih rendah pada manusia dan metode-metode untuk menyusun, mengidentifikasi dan menghasilkan protein-protein semacam itu | |
DK296087D0 (da) | Peptidmateriale og fremgangsmaade til paavisning af antistoffer til htlv-iii | |
CY1112229T1 (el) | Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β | |
KR970027305A (ko) | 인간 혈장 아포지단백질(apolipoprotein) B-100에 결합하는 생쥐 항체를 암호하는 cDNA | |
Tian et al. | Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease | |
DE69635582D1 (de) | Diagnostika und behandlungen von peridontalen erkrankungen | |
PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
SE0302422D0 (sv) | Peptide-based immunization therapy for treatment of atherosclerosis | |
DE60336214D1 (de) | Methoden zur analyse von antikörperdisulfidisomere | |
BRPI0216033B8 (pt) | "terapia de imunização à base de peptídio para tratamento de arteriosclerose" | |
DE69333111D1 (de) | Natürliche menschliche igm antikörper | |
SE0202959D0 (sv) | Peptide-Base passive immunization therapy for treatment of atherosclerosis | |
SE0104354D0 (sv) | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |